Nuveen LLC Makes New Investment in BrightSpring Health Services, Inc. $BTSG

Nuveen LLC bought a new stake in BrightSpring Health Services, Inc. (NASDAQ:BTSG - Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 1,621,527 shares of the company's stock, valued at approximately $29,333,000. Nuveen LLC owned 0.93% of BrightSpring Health Services as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Vanguard Group Inc. increased its stake in BrightSpring Health Services by 24.6% in the first quarter. Vanguard Group Inc. now owns 6,633,744 shares of the company's stock valued at $120,004,000 after acquiring an additional 1,308,651 shares during the period. Invesco Ltd. boosted its position in BrightSpring Health Services by 41.0% in the first quarter. Invesco Ltd. now owns 6,172,597 shares of the company's stock valued at $111,662,000 after buying an additional 1,794,035 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its position in BrightSpring Health Services by 13.9% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 2,698,629 shares of the company's stock valued at $45,959,000 after buying an additional 328,977 shares in the last quarter. Sea Cliff Partners Management LP boosted its position in BrightSpring Health Services by 49.1% in the fourth quarter. Sea Cliff Partners Management LP now owns 1,735,150 shares of the company's stock valued at $29,550,000 after buying an additional 571,437 shares in the last quarter. Finally, T. Rowe Price Investment Management Inc. acquired a new position in BrightSpring Health Services in the fourth quarter valued at about $26,958,000.

BrightSpring Health Services Trading Up 3.1%

NASDAQ BTSG traded up $0.7380 during trading hours on Friday, hitting $24.6980. The company's stock had a trading volume of 650,812 shares, compared to its average volume of 2,052,558. The stock has a fifty day moving average of $21.47 and a 200 day moving average of $20.50. BrightSpring Health Services, Inc. has a twelve month low of $11.96 and a twelve month high of $25.57. The firm has a market capitalization of $4.38 billion, a P/E ratio of 79.84 and a beta of 2.25. The company has a quick ratio of 1.34, a current ratio of 1.76 and a debt-to-equity ratio of 1.43.

BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) last announced its quarterly earnings data on Friday, August 1st. The company reported $0.22 earnings per share for the quarter, beating the consensus estimate of $0.19 by $0.03. BrightSpring Health Services had a net margin of 0.55% and a return on equity of 9.29%. The business had revenue of $3.15 billion for the quarter, compared to analyst estimates of $2.99 billion. During the same period in the prior year, the business posted $0.10 earnings per share. BrightSpring Health Services's revenue was up 15.3% compared to the same quarter last year. BrightSpring Health Services has set its FY 2025 guidance at EPS. Equities research analysts forecast that BrightSpring Health Services, Inc. will post 0.59 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on BTSG. Wells Fargo & Company upped their target price on shares of BrightSpring Health Services from $25.00 to $27.00 and gave the stock an "overweight" rating in a research report on Tuesday, May 13th. Mizuho set a $26.00 price objective on BrightSpring Health Services in a report on Monday, May 5th. Cowen reaffirmed a "buy" rating on shares of BrightSpring Health Services in a report on Monday, August 4th. Wall Street Zen downgraded BrightSpring Health Services from a "strong-buy" rating to a "buy" rating in a report on Saturday, July 26th. Finally, TD Cowen started coverage on BrightSpring Health Services in a report on Monday, June 23rd. They set a "buy" rating and a $37.00 price objective on the stock. Ten investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $25.67.

Insider Activity at BrightSpring Health Services

In related news, insider Jon B. Rousseau sold 531,840 shares of the stock in a transaction that occurred on Thursday, June 12th. The shares were sold at an average price of $21.75, for a total value of $11,567,520.00. Following the transaction, the insider directly owned 1,184,133 shares in the company, valued at $25,754,892.75. This represents a 30.99% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, major shareholder Phoenix Aggregator L.P. Kkr sold 13,288,101 shares of the stock in a transaction that occurred on Thursday, June 12th. The shares were sold at an average price of $21.15, for a total transaction of $281,043,336.15. Following the completion of the transaction, the insider owned 79,671,883 shares in the company, valued at $1,685,060,325.45. This represents a 14.29% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 15,919,941 shares of company stock worth $337,025,856 over the last 90 days. 3.40% of the stock is currently owned by company insiders.

About BrightSpring Health Services

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.